Development of novel COVID-19 diagnostic tools

February 24th, 2021|

Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools LA JOLLA, CA— La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to [...]

Launch of COVID-19 Neutralization MICRO-ELISA Assay

September 3rd, 2020|

Leinco Technologies and ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma Leinco Technologies ("Leinco") ( St. Louis, MO), a biotechnology company and specialty manufacturer of antibodies, [...]

Leinco receives CODEX® licensing rights

April 22nd, 2020|

Akoya Biosciences, Inc. and Leinco Technologies, Inc. Announce Strategic Partnership for Customized CODEX Antibody Panel Design and Validation ST. LOUIS, April 22, 2020-- Leinco Technologies (St. Louis, MO) and Akoya Biosciences, (Menlo Park, CA) have [...]